ExVivo Labs is building a platform to detect allergies through the skin, without the need for blood. ExVivo's patch extracts a sample of interstitial skin fluid and analyzes it for the presence of the allergy biomarker, also known as IgE. This is the same biomarker that's found in blood, and is the basis for several blood tests currently on the market.
On September 15, 2016 ExVivo Labs announced raising a second undisclosed amount of seed funding from Y Combinator, Tencent Holdings, OS Fund, Fifty Years, and 1517 Fund.
On December 1, 2018 ExVivo Labs announced raising an undisclosed amount of venture funding from undisclosed investors.
Mark H Goldstein
Creating compact and microscale features in paper-based devices by laser cutting - Analyst (RSC Publishing)
Md. Almostasim Mahmud, Eric J. M. Blondeel, Moufeed Kaddoura and Brendan D. MacDonald
Minimally-invasive, microneedle-array extraction of interstitial fluid for comprehensive biomedical applications: transcriptomics, proteomics, metabolomics, exosome research, and biomarker identification
Robert M Taylor, Philip R Miller, Parwana Ebrahimi, Ronen Polsky, Justin T Baca
Structure and Distribution of an Unrecognized Interstitium in Human Tissues
Darren Buonocore, Susan Kornacki, Neil D. Theise, Michael Wayne, Heather Klavan, Markus Miranda, Jason Reidy, Bridget Sackey-Aboagye, Rebecca G. Wells, Petros C. Benias, David L. Carr-Locke
Documentaries, videos and podcasts
- StartupA startup company is an entrepreneurial venture in the initial stage of its operations. Startups are typically young businesses aiming to grow quickly and meet a marketplace need by developing or offering an innovative product, process or service.
- CompanyA company, abbreviated 'co.', is a legal entity made up of an association of people, be they natural, legal, or a mixture of both, for carrying on a commercial or industrial enterprise.